{"entity":{"id":"jiang-yi-zhou","kind":"person","name":"Yi-Zhou Jiang","aka":[],"tldr":"Co-architect of the Fudan TNBC subtypes and the metabolic and immune atlases that guide subtype-specific treatment.","summary":"Yi-Zhou Jiang is Professor of Breast Surgery at Fudan University Shanghai Cancer Center. He is co-architect of the Fudan subtypes of triple-negative breast cancer and led the multi-omic characterisation of Chinese triple-negative breast cancers, including the metabolomic and immune atlases that guide subtype-specific treatment. His publications include the genomic and transcriptomic landscape of triple-negative breast cancers and the treatment strategies it suggests. He co-leads the FUTURE trial series with Zhi-Ming Shao, with interests in multi-omics, metabolomics, proteomics and precision oncology.","asOf":"2026-09-08","links":[{"label":"Fudan University Shanghai Cancer Center","url":"https://www.shca.org.cn"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Jiang%20YZ%5BAuthor%5D%20triple-negative%20breast%20cancer%20Fudan"}],"tags":[],"related":[],"cancers":["tnbc"],"sections":[],"technologies":["proteomics","rna-seq"],"targets":[],"drugs":[],"companies":[],"institutions":["fuscc"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Professor of Breast Surgery, Fudan University Shanghai Cancer Center","institutionId":"fuscc","specialisms":["Triple-negative breast cancer","Multi-omics","Metabolomics","Precision oncology"],"profiles":[{"label":"Fudan University Shanghai Cancer Center","url":"https://www.shca.org.cn"},{"label":"PubMed author search","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Jiang%20YZ%5BAuthor%5D%20triple-negative%20breast%20cancer%20Fudan"}],"papers":[{"title":"Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies","journal":"Cancer Cell","year":2019,"doi":"10.1016/j.ccell.2019.02.001"}]},"route":"/people/jiang-yi-zhou/","neighbours":{"cancer":[{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"technology":[{"id":"proteomics","kind":"technology","name":"Proteomics & phosphoproteomics","route":"/technologies/proteomics/"},{"id":"rna-seq","kind":"technology","name":"RNA sequencing & expression profiling","route":"/technologies/rna-seq/"}],"institution":[{"id":"fuscc","kind":"institution","name":"Fudan University Shanghai Cancer Center","route":"/institutions/fuscc/"}],"paper":[{"id":"paper-jiang-fuscc-tnbc-landscape-cancer-cell-2019","kind":"paper","name":"Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies","route":"/key-papers/paper-jiang-fuscc-tnbc-landscape-cancer-cell-2019/"}]}}